Skip to main content

Table 2 Proton-pump inhibitor dispensing prevalence in 2015 by sex and age (%)

From: Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015

   < 16 16–24 25–44 45–64  > 65 Total
Men
 Omeprazole 0.29 2.40 6.77 16.89 47.73 14.60
 Pantoprazole 0.00 0.04 0.21 0.66 2.13 0.59
 Lansoprazole 0.01 0.05 0.12 0.49 1.27 0.38
 Rabeprazole 0.00 0.02 0.06 0.18 0.51 0.15
 Esomeprazole 0.04 0.06 0.23 0.48 1.03 0.38
 Total 0.32 2.53 7.19 18.23 51.36 15.69
Women
 Omeprazole 0.31 3.56 7.99 20.04 53.13 19.00
 Pantoprazole 0.01 0.10 0.26 0.84 2.02 0.73
 Lansoprazole 0.01 0.09 0.13 0.67 1.74 0.59
 Rabeprazole 0.00 0.01 0.08 0.28 0.69 0.24
 Esomeprazole 0.01 0.13 0.22 0.73 1.27 0.53
 Total 0.33 3.78 8.42 21.73 57.18 20.43
All
 Omeprazole 0.30 2.96 7.35 18.40 50.78 16.78
 Pantoprazole 0.01 0.07 0.23 0.75 2.06 0.66
 Lansoprazole 0.01 0.07 0.13 0.58 1.54 0.48
 Rabeprazole 0.00 0.02 0.07 0.23 0.61 0.20
 Esomeprazole 0.03 0.09 0.23 0.60 1.17 0.45
 Total 0.33 3.13 7.77 19.91 54.64 18.04